Form NT 20-F - Notification of inability to timely file Form 20-F:
SEC Accession No. 0001104659-25-043006
Filing Date
2025-05-01
Accepted
2025-05-01 07:00:29
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-05-01

Document Format Files

Seq Description Document Type Size
1 NT 20-F tm251325d2_nt20f.htm NT 20-F 23333
  Complete submission text file 0001104659-25-043006.txt   24413
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: NT 20-F | Act: 34 | File No.: 001-40858 | Film No.: 25899334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)